CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		118 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,191,593)	$ (2,662,979)	$ (18,936,800)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	18,420	18,453	274,408
Non-cash fair value of common stock issued for consulting	45,550	110,500	179,538
Share-based compensation related to employee stock options	371,912	265,354	3,056,859
Amortization of debt discount			19,292
Non-cash fair value of stock options issued to non-employees for consulting	153,761	4,642	1,528,513
Non-cash fair value of warrants issued to non-employees		73,220	134,420
Expenses paid by issuance of preferred and common stock		70,000	247,650
Loss on fixed asset dispositions			72,695
Non-cash interest expense on beneficial conversion	27,500		27,500
Gain on debt and accounts payable settlement	(6,594)	(133,142)	(1,622,752)
Loss on early extinguishment of debt			61,419
Net loss on sale of trading securities	828		828
Unrealized loss on trading securities	232,859		232,859
Gain on revaluation of derivative warrant liabilitiy	(55,576)		(55,576)
(Increase) decrease in:
Accounts receivable			50,000
Prepaid expenses and other	51,129	(63,773)	(26,181)
Increase (decrease) in:
Accounts payable	277,048	(114,336)	927,077
Accrued expenses	73,524	(18,482)	667,034
Net Cash Used by Operating Activities	(2,001,232)	(2,450,543)	(13,161,217)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of investments, net	13,940		13,940
Cash paid for intangible assets			(161,609)
Net cash received in acquisition			69
Cash paid for purchase of property and equipment	(2,046)	(38,435)	(415,018)
Net Cash Used by Investing Activities	11,894	(38,435)	(562,618)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes - stockholders, net	330,000		1,730,000
Proceeds from issuance of short-term convertible notes			608,165
Advances from stockholders			679,500
Proceeds from sale of common stock, net			8,430,920
Proceeds from sale of preferred stock, net	478,185		2,398,185
Net Cash Provided by Financing Activities	808,185		13,846,770
Net Increase (Decrease) in Cash and Cash Equivalents	(1,181,153)	(2,488,978)	122,935
Cash and Cash Equivalents, Beginning of Period	1,304,088	3,265,141
Cash and Cash Equivalents, End of Period	122,935	776,163	122,935
Supplemental Cash Flow Disclosures:
Interest expense paid in cash
Tax paid	1,662
Supplemental Non-Cash Disclosure:
Conversion of preferred stock to common stock			288
Notes payable - stockholder - settled in common stock			2,135,000
Accrued interest - stockholder - settled in common stock			188,569
Notes payable - stockholder - settled in preferred stock	275,000		2,135,000
Accrued interest - stockholder - settled in common stock			188,569
Preferred Stock Dividend	(1,497,981)	(124,137)	(2,643,314)
Advances from stockholders settled in common stock			679,500
Accounts payable settled in common stock			471,472
Accounts payable settled in common stock options			30,500
Accrued expenses settled in common stock options			3,000
Decrease in accounts payable related to fixed asset disposition			133,314
Decrease in accounts payable related to settlement	6,594	133,142	1,622,752
Decrease in accrued expenses related to settlement			3,000
Increase in accounts receivable related to common stock issuance			50,000
Warrants issued with convertible notes payable			7,474
Accrued expenses settled in preferred stock	15,000		15,000
Sale of preferred stock for marketable equity securities	3,495,385		3,495,385
Fair value of warrants issued to Series B holders	2,183,161		2,183,161
Fair value of warrants issued to Series B placement agents	$ 22,499		$ 22,499